This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom
The drug HBVAXPRO contains one active pharmaceutical ingredient (API):
|
1
Hepatitis B surface antigen (HBS AG) recombinant
UNII IFJ010MNE4 - HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN
|
|
Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| HBVAXPRO Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07BC01 | Hepatitis B, purified antigen | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1199684, 1199695, 1199707, 1199718, 1199831, 1199842, 1199853, 1199875, 1199886, 1199897, 1213535, 1213557 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 01183015, 01183024, 01183028 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 007556, 113606 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 64646891, 69352630 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 107518, 107521, 29879 |
| Country: HK | Department of Health Drug Office | Identifier(s): 50265, 50266 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 035262017, 035262029, 035262031, 035262043, 035262056, 035262068, 035262070, 035262082, 035262094, 035262106, 035262118, 035262120, 035262132, 035262144, 035262157, 035262169, 035262171, 035262183, 035262195, 035262207, 035262219, 035262221, 035262233, 035262245, 035262258, 035262260, 035262272, 035262284, 035262296, 035262308, 035262310, 035262322 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1028739, 1028740, 1028741, 1028742, 1028743, 1028744, 1028745, 1028746, 1028747, 1028748, 1028749, 1028750, 1028751, 1028752, 1028753, 1028754, 1028755, 1028756, 1028757, 1028758, 1056679, 1056680, 1056681 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14736195, 14736209 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 83844, 83852, 90581 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 3584, 3585 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100110406, 100250656, 100250662 |
| Country: SG | Health Sciences Authority | Identifier(s): 12519P, 13089P, 13092P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699636960066, 8699636960110 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
